This Medical Technology Leader Sees Growth Into The 2040s

This Medical Technology Leader Sees Growth Into The 2040s | Investor's Business DailySPECIAL REPORT: [Find The Online Broker That Best Fits Your Needs]---Medical technology leader Halozyme Therapeutics (HALO) is this week's IBD Sector Leaders selection, having bypassed two buy points and entered a buy zone. The recent IBD Stock Of The Day is rallying after the company raised its 2025 and 2026 outlook. It also offered a bold forecast for 2027, 2028 and beyond. The biopharmaceutical company's enzyme technolog ...